Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis
Clinical trial NCT02135536 · COMPLETED
Trial details
- NCT number
- NCT02135536
- Sponsor
- NGM Biopharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2016-02-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.